Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 13. Juli 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16602  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 332026  
   
Risk factors associated with molecular subtypes of breast cancer among indian women: a multicentre matched case-control study.
Breast Cancer
George PS, Mathew A, Kaur T, Dhaliwal RS, Nair RA, Tanwar P, Hussain S, Agrawal U, Rath GK, Breast Cancer Task Force Study Group.
PMID: 42440003 [PubMed - as supplied by publisher]


Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life.
Cancer Chemother Pharmacol
Scontre VA, Toyoshima MTK, Estevez-Diz MDP.
PMID: 42439956 [PubMed - indexed for MEDLINE]


Comparative Efficacy of Poly-ADP-Ribose Polymerase Inhibitors (Parpis) in the Treatment of Advanced Ovarian Cancer in Younger and Elderly Patients: A Systematic Review and Meta-Analysis.
Anticancer Agents Med Chem
Feng Y, Zhang Y, Hu J, He Y, Liu J.
PMID: 42439329 [PubMed - as supplied by publisher]


Mechanistic Links Between Obesity and Breast Cancer Progression: Cellular Crosstalk, Metabolic Reprogramming and Microenvironmental Drivers.
Cell Biochem Funct
Basson C, Pepper MS, Joubert AM, Ambele MA.
PMID: 42439024 [PubMed - indexed for MEDLINE]


Prognostic analysis according to adjuvant chemotherapy and anti-HER2 therapy following surgery in T1a/b HER2-positive breast cancer.
Korean J Intern Med
Park W, Suh KJ, Seo J, Kim SH, Kim YJ, Shin HC, Kim EK, Kim IA, Park SY, Kim JH.
PMID: 42438913 [PubMed - indexed for MEDLINE]


Optimizing in-context exemplars for a generalist vision-language model to support region of interest selection in ovarian tumor grossing.
iScience
He D, Jin L, Mei X, Jia M, Wang Z, Ren B, Cao L.
PMID: 42438828 [PubMed]


Multiparametric MRI-Based Prediction Model for Sentinel Lymph Node Metastasis in Breast Cancer: Integrating Quantitative Imaging Parameters and Reproductive History.
Int J Womens Health
Zhang Y, Wang Z, Li Z, Yuan Z, Liu T, Hou H, Ye Z, Wang W, Zhang X.
PMID: 42438478 [PubMed]


Tanshinone IIA in breast cancer: Molecular mechanisms, structural optimization and translational challenges (Review).
Oncol Rep
Li X, Feng L.
PMID: 42438255 [PubMed - indexed for MEDLINE]


Impact of Treatment Modality on Pain, Sexual Function, and Psychological Well-Being in Patients With Bartholin's Duct Cyst and Abscess: A Prospective Observational Cohort Study.
Med Sci Monit
Ayçiçek S, Kayaalp H.
PMID: 42438181 [PubMed - indexed for MEDLINE]


Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study.
J Natl Cancer Inst
Tarantino P, Curigliano G, Hamilton E, Kim J, Graff SL, Neven P, Schlam I, Harbeck N, Cardoso F, Akdere M, Santarsiero L, Ye F, Angehrn Z, Jhaveri K.
PMID: 42438162 [PubMed - as supplied by publisher]


Risk of venous thromboembolism with CDK 4/6 inhibitor use in breast cancer: A systematic review and meta-analysis.
Oncologist
Cortez E, Luna ET, Ibarra MB, Riojas Suárez IE, Garcia-Perdomo HA, Rojas Hernandez CM.
PMID: 42438148 [PubMed - as supplied by publisher]


Management and Outcomes of Uterine Smooth Muscle Tumour of Uncertain Malignant Potential (STUMP).
Cancer Med
Chan AHY, Chan KKL, Ip PPC, Tse KY.
PMID: 42438070 [PubMed - indexed for MEDLINE]


Causal relationship and pathogenic mechanism analysis of breast cancer and coronary heart disease based on mendelian randomization and transcriptome data analysis.
Immunogenetics
Xie M, Wu Y, Jin X, Jiang F, Yao Q.
PMID: 42437780 [PubMed - indexed for MEDLINE]


Prognostic Impact of WHO 2020 Lymphovascular Space Invasion Categories in Endometrial Cancer: Substantial LVSI as an Independent Risk Factor and the Behavior of LVSI-Positive, Node-Negative Disease.
J Obstet Gynaecol Res
Ege G, Öncü HN, Ege HV, Öztürk N, Baydemir , Köksal OK, Hanedan C.
PMID: 42437687 [PubMed - indexed for MEDLINE]


Reframing Response in Neoadjuvant Chemotherapy for Ovarian Cancer: Integrating Molecular and Functional Biomarkers.
Crit Rev Oncol Hematol
Klasa-Mazurkiewicz D, Koronowicz M, , Supernat A.
PMID: 42437630 [PubMed - as supplied by publisher]


Etomidate combined with TAPB in ovarian cancer surgery: A controlled study on hemodynamics and immune response.
Pak J Pharm Sci
Xie J, Li X, Jian F.
PMID: 42437334 [PubMed - indexed for MEDLINE]


Analysis of the Correlation between the Pan-immune Inflammation Value and the Prognosis of Patients with Endometrial Cancer.
Iran J Allergy Asthma Immunol
Wang W, Jin Y, Yang Y.
PMID: 42437316 [PubMed - indexed for MEDLINE]


ESR1 and PIK3CA circulating tumor DNA (ctDNA) mutation status as predictive biomarkers beyond variant allele fraction (VAF) in metastatic breast cancer.
J Liq Biopsy
Fusco N, Malapelle U.
PMID: 42437171 [PubMed]


Bilateral L3-L4 pedicular insufficiency fractures in a patient with breast cancer and treated spinal metastasis: A diagnostic pitfall.
Radiol Case Rep
Alsobehi N, Adas R.
PMID: 42437148 [PubMed]


TransBreast-Net: An interpretable vision transformer ensemble for breast cancer histopathology classification.
J Pathol Inform
Uddin KMM, Adnan MA.
PMID: 42436741 [PubMed]


   
   Artikel 1 - 20 / 332026    Seite 1 von 16602  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1